Clinical Trial Update: Study to Evaluate the Effects of Switching Different Strength Forms of FK949E in Bipolar Disorder Patients With Major Depressive Episodes [Phase 3]

View source ↗

Summary

Phase 3 trial assessing switching between different strength forms of FK949E in bipolar depression; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• FK949E

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Bipolar Depression | Phase 3 | Status: COMPLETED | Results posted: 2017-03-17